HL Financial Services’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-3,854
| Closed | -$306K | – | 704 |
|
|
2016
Q4 | $306K | Sell |
3,854
-2,646
| -41% | -$210K | 0.01% | 549 |
|
|
2016
Q3 | $455K | Hold |
6,500
| – | – | 0.01% | 442 |
|
|
2016
Q2 | $252K | Hold |
6,500
| – | – | 0.01% | 572 |
|
|
2016
Q1 | $263K | Hold |
6,500
| – | – | 0.01% | 553 |
|
|
2015
Q4 | $576K | Hold |
6,500
| – | – | 0.01% | 413 |
|
|
2015
Q3 | $481K | Sell |
6,500
-1,500
| -19% | -$111K | 0.01% | 430 |
|
|
2015
Q2 | $647K | Hold |
8,000
| – | – | 0.02% | 404 |
|
|
2015
Q1 | $335K | Buy |
+8,000
| New | +$335K | 0.01% | 542 |
|